Document Detail


The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver.
MedLine Citation:
PMID:  8678767     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare the accuracy of whole-body position emission tomography (PET)using [18F]fluorodeoxyglucose (FDG) with conventional radiological imaging techniques in identifying operable colorectal cancer metastases to the liver. DESIGN: A double-blind comparative study of FDG-PET as the criterion standard vs conventional radiological imaging methods as the criterion standard, in staging of recurrent colorectal cancer. SETTING: Institutional practice in a tertiary referral center. PATIENTS: Thirty-four consecutive patients with suspected colorectal cancer metastases recruited for the study between May 1993 and October 1994. INTERVENTIONS: Conventional radiological methods of cancer staging included abdominal computed tomography (CT) (n = 34), chest x-rays (n = 15), and chest CT (n = 19) to evaluate extrahepatic disease. Twenty-seven patients were subsequently considered to have apparently isolated cancer metastases to the liver. Anatomical resectability was assessed by magnetic resonance imaging (n = 24) or CT angiography (n = 3) in all study patients. The FDG-PET studies (n = 34) were performed within 8 weeks of conventional radiological imaging. MAIN OUTCOME MEASURES: Malignancy of suspected lesions detected by means of FDG-PET and conventional radiological imaging was confirmed by histopathologic examination of resected specimens and percutaneous biopsy specimens and by serial CT scans demonstrating progression of disease. RESULTS: Unsuspected extrahepatic malignant disease that was missed by conventional radiological imaging was detected by FDG-PET in 11 patients (32%). The PET-detected extrahepatic malignant disease included retroperitoneal nodal metastases (n = 6), pulmonary metastases (n = 3), and locoregional cancer recurrences (n = 2). The additional information afforded by PET consequently had an influence on the clinical management in 10 patients (29%). CONCLUSIONS: The FDG-PET method enabled selection of patients with apparently curable colorectal cancer metastases to the liver for hepatic resection.
Authors:
D T Lai; M Fulham; M S Stephen; K M Chu; M Solomon; J F Thompson; D M Sheldon; D W Storey
Related Documents :
17610107 - Preoperative staging of colorectal cancer: ct vs. integrated fdg pet/ct.
10551237 - Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-anal...
16053847 - The role of gamma-pet in the evaluation of patients with recurrent squamous cell cancer...
11150757 - 9:45-10:00. positron emission tomography (pet) is superior to computerized tomography (...
7489297 - Mr imaging of the patellofemoral compartment.
19370427 - Dosimetric comparison of image guidance by megavoltage computed tomography versus bone ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Archives of surgery (Chicago, Ill. : 1960)     Volume:  131     ISSN:  0004-0010     ISO Abbreviation:  Arch Surg     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1996-08-15     Completed Date:  1996-08-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9716528     Medline TA:  Arch Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  703-7     Citation Subset:  AIM; IM    
Affiliation:
Department of Upper Gastrointestinal Surgery, Royal Prince Alfred Hospital, Camperdown, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Colorectal Neoplasms / pathology*
Deoxyglucose / analogs & derivatives*,  diagnostic use
Double-Blind Method
Fluorine Radioisotopes / diagnostic use*
Fluorodeoxyglucose F18
Humans
Liver Neoplasms / radiography,  radionuclide imaging*,  secondary*
Neoplasm Recurrence, Local
Tomography, Emission-Computed*
Chemical
Reg. No./Substance:
0/Fluorine Radioisotopes; 154-17-6/Deoxyglucose; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.
Next Document:  Adenocarcinoma in the distal esophagus with and without Barrett esophagus. Differences in symptoms a...